
Spring 2024
By Colleen Sullivan
With their latest commitment of $300,000, the Pancreatic Cancer Action Network is supporting the work of Dana-Farber’s Andrew Aguirre, MD, PhD, who aims to identify the mechanisms of response or resistance to a combination treatment for pancreatic cancer.
